bioLytical Laboratories Inc. Announces Health Canada Authorization of its rapid INSTI® HCV Antibody Test for Professional Use in Canada bioLytical Laboratories Inc. announced today the immediate availability of its INSTI® HCV Antibody Test in the Canadian market

bioLytical Laboratories Inc. Announces Launch of its INSTI® HCV Antibody Test for Professional Use in Australia bioLytical launches the INSTI® HCV Antibody Test in Australia with its inclusion on the Australian Register of Therapeutic Goods (ARTG number: 448926)

Hepatitis C Virus Testing Market Poised to Expand at a 5.8% CAGR, Surpassing US$1,185.2 Million by 2030 | Persistence Market Research New York, Jan. 19, 2024 (GLOBE NEWSWIRE) -- Market Overview: The Hepatitis C Virus (HCV) Testing Market is a dynamic and evolving sector within the healthcare industry, driven by the persistent...